Especially given how quickly we are trying to develop a COVID-19 vaccine, it’s a good sign that the AstraZeneca trial paused to investigate an unexplained illness, commented Susan Ellenberg, PhD.
Especially given how quickly we are trying to develop a COVID-19 vaccine, it’s a good sign that the AstraZeneca trial paused to investigate an unexplained illness, commented Susan Ellenberg, PhD.